Helius Medical Technologies, Inc. (HSDT)
NASDAQ: HSDT · Real-Time Price · USD
0.452
-0.001 (-0.26%)
Nov 20, 2024, 4:00 PM EST - Market closed
HSDT Stock Forecast
HSDT's stock price has decreased by -93.54% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for HSDT stock has a target of 24, which predicts an increase of 5,207.39% from the current stock price of 0.45.
Analyst Consensus: Buy
* Price targets were last updated on Mar 5, 2024.
Analyst Ratings
The average analyst rating for HSDT stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Oct 16, 2024 |
| Roth MKM | Roth MKM | Strong Buy Maintains $5 → $24 | Strong Buy | Maintains | $5 → $24 | +5,207.39% | Mar 5, 2024 |
| Maxim Group | Maxim Group | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +10,957.05% | Dec 20, 2022 |
| Roth Capital | Roth Capital | Strong Buy Initiates $250 | Strong Buy | Initiates | $250 | +55,185.27% | Aug 23, 2022 |
| Noble Capital Markets | Noble Capital Markets | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Nov 15, 2021 |
Financial Forecast
Revenue This Year
749.70K
from 644.00K
Increased by 16.41%
Revenue Next Year
989.40K
from 749.70K
Increased by 31.97%
EPS This Year
-5.77
from -14.56
EPS Next Year
-2.46
from -5.77
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 771,750 | 1.0M | 21.3M |
| Avg | 749,700 | 989,400 | 20.7M |
| Low | 720,300 | 950,600 | 19.9M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 19.8% | 35.9% | 2,057.6% |
| Avg | 16.4% | 32.0% | 1,995.9% |
| Low | 11.8% | 26.8% | 1,913.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -5.94 | -2.53 | 2.40 |
| Avg | -5.77 | -2.46 | 2.34 |
| Low | -5.55 | -2.36 | 2.24 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.